Skip to main content

NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.

Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.

U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Certification of Standard Reference Material® 1595a Tripalmitin

Published

Author(s)

Michael Nelson, Jerome Mulloor, Brian Lang, Blaza Toman, Antonio Possolo, William Perry, Alicia Lyle

Abstract

Standard Reference Material (SRM) 1595a Tripalmitin is a high purity chemical substance having a certified value for purity, expressed as a mass fraction. It is intended for use in preparing calibrants for measurement of total glyceride in clinical samples. A unit of SRM 1595a consists of one bottle containing 2 g of tripalmitin powder. This publication documents the production, analytical methods, and computations involved in characterizing this product.
Citation
Special Publication (NIST SP) - 260-243
Report Number
260-243

Keywords

glyceride standard, tripalmitin, quantitative NMR, purity, measurement calibration, SI traceability

Citation

Nelson, M. , Mulloor, J. , Lang, B. , Toman, B. , Possolo, A. , Perry, W. and Lyle, A. (2024), Certification of Standard Reference Material® 1595a Tripalmitin, Special Publication (NIST SP), National Institute of Standards and Technology, Gaithersburg, MD, [online], https://doi.org/10.6028/NIST.SP.260-243, https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=957259 (Accessed October 13, 2025)

Issues

If you have any questions about this publication or are having problems accessing it, please contact [email protected].

Created March 1, 2024
Was this page helpful?